Bg pattern

INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show translation

Introducción

Prospecto: información para el usuario

Cloruro de indio (111In) Curium Pharma Spain 370 MBq/ml precursor radiofarmacéutico en solución

Cloruro de indio (111In)

Lea todo el prospecto detenidamente antes de que este medicamento sea mezclado con otros compuestos y se le administre, porque contiene información importante para usted.

  • Conserve este prospecto, ya que puede tener que volver a leerlo.
  • Si tiene alguna duda, consulte a su médico nuclear que supervisa el procedimiento.
  • Si experimenta efectos adversos, consulte a su médico nuclear, incluso si se trata de efectos adversos que no aparecen en este prospecto. Ver sección 4.

Contenido del prospecto:

  1. Qué es Cloruro de indio (111In) Curium Pharma Spain y para qué se utiliza
  2. Qué necesita saber antes de empezar a usar Cloruro de indio (111In) Curium Pharma Spain
  3. Cómo usar Cloruro de indio (111In) Curium Pharma Spain
  4. Posibles efectos adversos
  5. Conservación de Cloruro de indio (111In) Curium Pharma Spain
  6. Contenido del envase e información adicional

1. Qué es Cloruro de indio (111In) Curium Pharma Spain y para qué se utiliza

Este medicamento es un radiofármaco únicamente para uso diagnóstico.

Cloruro de indio (111In) Curium Pharma Spain pertenece al grupo de los medicamentos denominados radiofármacos compuestos de indio (111In). Este radiofármaco se une a determinadas sustancias y posteriormente se inyecta en el paciente. Debido a que el radiofármaco contiene una pequeña cantidad de radiactividad, puede detectarse desde el exterior del cuerpo utilizando un equipo médico especial denominado gammacámara y se puede obtener una imagen, conocida como gammagrafía. Esta gammagrafía mostrará exactamente la distribución del radiofármaco en un órgano determinado y en el cuerpo. Esto puede dar al médico información valiosa en cuanto a la estructura y función de ese órgano.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. Qué necesita saber antes de empezar a usar Cloruro de indio (111In) Curium Pharma Spain

Antes de administrarle este medicamento lea las advertencias del medicamento al que va a unirse este radiofármaco.

Cloruro de indio (111In) Curium Pharma Spainno debe utilizarse:

Si es alérgico (hipersensible) al principio activo o a cualquiera de los demás componentes de Cloruro de indio (111In) Curium Pharma Spain (incluidos en la sección 6).

Advertencias y precauciones

Tenga especial cuidado con Cloruro de indio (111In) Curium Pharma Spain:

  • Cuando se le administre este medicamento porque supone la exposición a pequeñas cantidades de radiación. Aunque su médico siempre considerará los posibles riesgos y beneficios.
  • Si está embarazada o cree que pudiera estarlo.
  • Si está en periodo de lactancia.

Antes de la administración de cloruro de indio debe:

  • beber mucha agua antes de comenzar el procedimiento para orinar muy frecuentemente durante las primeras horas tras su finalización.

Si usted tiene disminuida la función de sus riñones porque es posible que aumente su exposición a la radiación.

Niños y adolescentes

Comunique a su médico nuclear si tiene menos de 18 años.

Uso de Cloruro de indio (111In) Curium Pharma Spain con otros medicamentos:

Informe a su médico nuclear si está tomando, ha tomado recientemente o podría tener que tomar cualquier otro medicamento, ya que algunos medicamentos pueden interferir en la interpretación de las imágenes por su médico.

Embarazo, lactancia y fertilidad

Debe informar al médico nuclear antes de la administración de Cloruro de indio (111In) Curium Pharma Spain si hay alguna posibilidad de que pueda estar embarazada, si presenta un retraso en la menstruación o si está en período de lactancia.

En caso de duda, es importante que consulte a su médico nuclear que supervisa el procedimiento.

Si está embarazada:

El médico nuclear sólo le administrará este medicamento durante el embarazo si se espera que el beneficio supere al riesgo.

Si está en periodo de lactancia:

Por favor, consulte a su médico nuclear cuándo puede reanudar la lactancia.

Pregunte a su médico nuclear antes de tomar ningún medicamento.

Conducción y uso de máquinas

No se han descrito efectos sobre la capacidad para conducir y utilizar máquinas.

Cloruro de indio (111In) Curium Pharma Spain contiene sodio.

Este medicamento contiene menos de 1 mmol de sodio (23 mg) por dosis, por lo que se considera esencialmente "exento de sodio".

3. Cómo usar Cloruro de indio (111In) Curium Pharma Spain

Hay normas estrictas sobre el uso, manipulación y eliminación de radiofármacos. Cloruro de indio (111In) Curium Pharma Spain se usará únicamente en áreas controladas especiales. Este producto solo será manejado y le será administrado por personal entrenado y cualificado para usarlo de forma segura. Esas personas pondrán especial cuidado en el uso seguro de este producto y le informarán de sus acciones.

El médico nuclear que supervise el procedimiento decidirá la cantidad de Cloruro de indio (111In) Curium Pharma Spain que debe usarse en su caso. Ésta será la cantidad mínima necesaria para obtener la información deseada.

La cantidad recomendada para administrar dependerá del medicamento a marcar.

Uso en niños y adolescentes

En niños y adolescentes la cantidad a administrar se adecuará a su peso corporal.

Administración de Cloruro de indio (111In) Curium Pharma Spain y realización del procedimiento

Cloruro de indio (111In) Curium Pharma Spain se administra por vía intravenosa, tras el marcaje de otro medicamento.

Una inyección es suficiente para realizar el procedimiento que su médico necesita.

Duración del procedimiento

Su médico nuclear le informará sobre la duración habitual del procedimiento.

Después de la administración de Cloruro de indio (111In) Curium Pharma Spain, usted debe

El médico nuclear le informará si necesita tomar alguna precaución especial tras recibir este medicamento. Contacte con su médico nuclear si tiene alguna duda.

Si se le ha administrado másCloruro de indio (111In) Curium Pharma Spaindel que debe

Puesto que este producto es administrado por un médico bajo condiciones de estricto control, es muy difícil cualquier sobredosis.

Sin embargo, en el caso de que se le administrara una dosis excesiva de este medicamento, deberá seguir las instrucciones que le indique el prospecto del medicamento al que se ha unido.

En caso de sobredosis o ingestión accidental, consulte al Servicio de Información Toxicológica. Teléfono 91 5620420.

Si tiene cualquier otra duda sobre el uso de Cloruro de indio (111In) Curium Pharma Spain, pregunte a su médico nuclear que supervisa el procedimiento.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Posibles efectos adversos

Al igual que todos los medicamentos, Cloruro de indio (111In) Curium Pharma Spain puede tener efectos adversos, aunque no todas las personas los sufran.

Además, pueden darse aquellas reacciones que se detallen en la información sobre el medicamento con el que se ha unido.

La administración de este radiofármaco implica recibir una pequeña cantidad de radiación ionizante con un riesgo muy bajo de desarrollar cáncer y defectos hereditarios.

Comunicación de efectos adversos

Si experimenta efectos adversos, consulte a su médico nuclear, incluso si se trata de efectos adversos que no aparecen en este prospecto. También puede comunicarlos directamente a través del Sistema Español de Farmacovigilancia de Medicamentos de Uso Humano: https://www.notificaram.es. Mediante la comunicación de efectos adversos usted puede contribuir a proporcionar más información sobre la seguridad de este medicamento.

5. Conservación de Cloruro de indio (111In) Curium Pharma Spain

No tendrá que almacenar este medicamento. Este medicamento se almacena bajo la responsabilidad del especialista en instalaciones apropiadas. El almacenamiento de radiofármacos se realizará conforme a la normativa nacional sobre materiales radiactivos.

La siguiente información está destinada únicamente al especialista.

El producto debe conservarse por debajo de 25ºC.

El almacenamiento debe realizarse en el contenedor plomado original o algún otro blindaje equivalente.

El almacenamiento debe realizarse conforme a la normativa nacional sobre materiales radiactivos.

No utilice Cloruro de indio (111In) Curium Pharma Spain después de la fecha de caducidad que aparece en la etiqueta del envase.

La fecha de caducidad es de 24 horas a partir de la fecha y hora de calibración.

6. Contenido del envase e información adicional

Composición de Cloruro de indio (111In) Curium Pharma Spain

  • El principio activo es cloruro de indio (111In). Cada ml de solución contiene 370 MBq de cloruro de indio (111In) en la fecha y hora de calibración.
  • Los demás componentes son: ácido clorhídrico y agua para preparaciones inyectables.

Aspecto del producto y contenido del envase

Este medicamento se presenta en forma de solución incolora. Se suministra en viales de vidrio estirado incoloro tipo I de la Ph. Eur. de 10 ml, sellados con tapón de goma de bromobutilo y con sobresello de aluminio.

Un envase contiene 1 vial con 0,3; 0,5; 1; 1,5 o 2 ml que corresponde con las siguientes actividades: 111, 185, 370, 555 o 740 MBq respectivamente, en la fecha y hora de calibración.

Titular de la autorización de comercialización y responsable de la fabricación:

Titular de la autorización de comercialización:

Curium Pharma Spain S. A.

Avenida Doctor Severo Ochoa Nº 29

28100, Alcobendas, Madrid

Responsable de la fabricación:

Curium Netherlands B.V.

Westerduinweg 3.

1755 LE Petten

Países Bajos

Fecha de la última revisión de este prospecto: marzo 2016

Otras fuentes de información

La información detallada y actualizada de este medicamento está disponible en la página Web de la Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) http://www.aemps.gob.es/

Esta información está destinada únicamente a médicos o profesionales del sector sanitario:

Se incluye la ficha técnica completa de Cloruro de indio (111In) Curium Pharma Spain como un documento separado en el envase del producto, con el fin de facilitar a los médicos o profesionales del sector sanitario información científica e información práctica sobre la administración y uso de este radiofármaco.

Por favor, consulte la ficha técnica.

Online doctors for INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION

Discuss questions about INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (5)
Doctor

Anastasiia Hladkykh

Psychiatry 15 years exp.

Dr Anastasiia Hladkykh is a physician-psychotherapist and psychologist with over 14 years of experience working with individuals struggling with various types of addictions and their families. She provides online consultations for adults, combining medical knowledge with deep psychological support and practical tools.

Key areas of expertise:

  • Addiction treatment: alcohol and drug dependence, gambling addiction, compulsive behaviours, codependent relationships.
  • Support for families of addicted individuals, behavioural correction within the family system, guidance for maintaining remission.
  • Mental health: depression, bipolar disorder, obsessive-compulsive disorder (OCD), anxiety disorders, phobias, PTSD, generalised anxiety, emotional trauma, and the psychological impact of loss or emigration.
  • Psychoeducation: explaining complex mental health concepts in simple language, helping patients and their families understand diagnoses and treatment steps.
Therapeutic approach:
  • Client-centred, straightforward, and empathetic – focused on practical outcomes and emotional stabilisation.
  • Prescribes medications when needed, but always aims to minimise unnecessary pharmaceutical use.
  • Certified in multiple evidence-based methods: CBT, NLP (Master Practitioner), Ericksonian hypnosis, symbol drama, art therapy, and systemic therapy.
  • Each consultation results in a clear, structured plan – patients leave knowing exactly what to do next.
Experience and background:
  • Member of the German association Gesundheitpraktikerin and the NGO “Mit dem Sonne in jedem Herzen.”
  • More than 18 publications in international peer-reviewed journals, translated into several languages.
  • Volunteer work with Ukrainian refugees and military personnel at the University Clinic of Regensburg.
Camera Book a video appointment
€130
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION?
INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
Who manufactures INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION?
INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION is manufactured by Curium Pharma Spain S.A.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to INDIUM(111) CHLORIDE CURIUM PHARMA SPAIN 370 MBq/ml RADIO-PHARMACEUTICAL PRECURSOR IN SOLUTION?
Other medicines with the same active substance () include OCTREOSCAN 111 MBq/ml KIT FOR RADIOPHARMACEUTICAL PREPARATION, ADREVIEW 74 MBq/ml INJECTABLE SOLUTION, AXUMIN 1600 MBq/ML INJECTABLE SOLUTION. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media